Compounds > n-(3-(aminomethyl)benzyl)acetamidine

n-(3-(aminomethyl)benzyl)acetamidine and dimethylarginine

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with dimethylarginine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
D'Alecy, LG; Song, MY; Whitesall, SE; Zwemer, CF1
Bil-Lula, I; Krzywonos-Zawadzka, A; Sawicki, G; Wozniak, M1

Other Studies

2 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and dimethylarginine

ArticleYear
Acute and conditioned hypoxic tolerance augmented by endothelial nitric oxide synthase inhibition in mice.
    Journal of applied physiology (Bethesda, Md. : 1985), 2007, Volume: 102, Issue:2

    Topics: Acute Disease; Animals; Arginine; Endothelium, Vascular; Enzyme Inhibitors; Hypoxia; Imines; Indazoles; Male; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroarginine; Time Factors

2007
A drug cocktail for protecting against ischemia-reperfusion injury.
    Frontiers in bioscience (Landmark edition), 2020, 01-01, Volume: 25, Issue:4

    Topics: Amidines; Animals; Arginine; Benzylamines; Enzyme Inhibitors; Heart; Male; Matrix Metalloproteinase 2; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Myosin Light Chains; Nitric Oxide; Nitric Oxide Synthase Type II; Protective Agents; Rats, Wistar

2020